基本信息
浏览量:129
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
Pier Francesco Ferrucci obtained his medical degree from the University of Pisa, Italy, and earned his Board Certification in Oncology at the University of Perugia, Italy. He went on to serve consecutive positions at the European Institute of Oncolgy in Milan, Italy, as a postdoctoral fellow in the Department of Experimental Oncology directed by Prof. PG Pelicci and then as a clinician within the Hematoncology Department and finally the Oncology Department directed by Prof. A. Goldhirsch as the Director of the Melanoma and Cutaneous Tumors Unit. Dr. Ferrucci is currently Director of the Biotherapy of Tumors Unit at that same Institution. He serve as an active Scientific Reviewer and Editorial Board Member for several international peer reviewed Journals and maintains active memberships in several International Medical Societies. As a result of his experience and expertise, he has been a valued invited speaker at more than 80 national and international meetings, and is serving as President of the NIBIT (Italian Network for Bio-Immunotherapy of Tumors) Association which recently joined ENCI (European Network For Cancer Immunotherapy) as a founding member. Moreover, dr Ferrucci is the Chairman of the International Immunotherapy Conference CICON23 which will be held in Milan next september 2023. He is also the Founding Member and Scientific Director of the Focacci Foundation for funding basic and clinical research on cancer and sustain patients and their families. He has presided as Principal Investigator on over 40 clinical trials and he is the author of more than 140 publications in peer-reviewed journals, including: The New England Journal of Medicine, Lancet Oncology, Nature Medicine, Journal of Clinical Oncology, Annals of Oncology, Clinical Cancer Research, Cell, PNAS and Blood, among others. Primarily, his major research interests have included research in immunotherapy and vaccination treatments of solid tumors, combination strategies with I-O, genetics and proteomics of melanoma, assessment of new molecular markers for tumor progression, biochemical and immunological monitoring.
研究兴趣
论文共 283 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Jonathan S. Zager,Marlana Orloff,Pier Francesco Ferrucci,Junsung Choi,David J. Eschelman,Evan S. Glazer,Aslam Ejaz, J. Harrison Howard,Erika Richtig, Sebastian Ochsenreither,Sunil A. Reddy,Michael C. Lowe,
Annals of Surgical Oncologypp.1-2, (2024)
Annals of Surgical Oncology (2024)
Annals of Surgical Oncologypp.1-12, (2024)
Annals of Surgical Oncology (2024)
European Journal of Cancerpp.113981-113981, (2024)
Annals of Surgical Oncologypp.1-2, (2024)
Jonathan S Zager,Marlana Orloff,Pier Francesco Ferrucci,Junsung Choi,David J Eschelman,Evan S Glazer,Aslam Ejaz, J Harrison Howard,Erika Richtig, Sebastian Ochsenreither,Sunil A Reddy,Michael C Lowe,
Annals of surgical oncology (2024)
Zenodo (CERN European Organization for Nuclear Research)no. 1 (2024): 1-12
Cancer immunology, immunotherapy : CIIno. 7 (2023): 2541-2548
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn